Common use of Activity Clause in Contracts

Activity. The Activity is made up of the Grantee’s project and all eligible project activities as specified in these Grant Details. In undertaking the Activity, the Grantee must comply with the requirements of the grant opportunity guidelines (as in force at the time of application). The Grantee must notify the Commonwealth about events relating to the project and provide an opportunity for the Minister or their representative to attend. The Grantee must ensure that the grant from the MRFF is appropriately badged and acknowledged in any correspondence, public announcement and publicly available materials including: reporting of key findings; presentations; and publications relating to this activity. Project title <project title> Project scope and description <detailed project description> Project outcomes <project outcomes> Dissemination of Research Findings The Grantee will ensure that appropriate safeguards are in place to protect patient privacy, Intellectual property and commercially confidential information for all Activities funded under this Project. The Grantee is encouraged to ensure that research activities are published and translated into clinical practice. Types of research dissemination may include, making lay summaries available for research participants, and presenting at specific forums. The Grantee is also encouraged to publish de-identified research data in an open access repository and in accordance with best practice. Duration of the Grant The Activity starts on <project start date> and ends on <project end date>, which is the Activity Completion Date. The Agreement ends on <agreement end date> which is the Agreement End Date. Activity Schedule In undertaking the Activity, the Grantee will meet the following milestones by the due dates. Milestone number Milestone name and description Due date <No> <milestone name> <milestone description> <dd/mm/yyyy> Payment of the Grant The total amount of the Grant is <grant amount> (plus GST if applicable). The Grant will be provided at up to <grant percentage> per cent of eligible expenditure as defined in the grant opportunity guidelines subject to availability of Program funds. The Grant will be paid in accordance with clause ST2.. The Grant will be paid according to the following schedule. Payments are subject to satisfactory progress on the project and compliance by the Grantee with its obligations under this Agreement. Payment event Payment amount (GST excl) Anticipated payment date <Payment trigger> <insert amount> <insert date> <Payment trigger> <insert amount> <insert date> Total <total grant amount> Invoicing The Grantee agrees to allow the Commonwealth to issue it with a Recipient Created Tax Invoice (RCTI) for any taxable supplies it makes in relation to the Activity.

Activity. The Activity is made up of the Grantee’s project and all eligible project activities as specified in these Grant Details. In undertaking the Activity, the Grantee must comply with the requirements of the grant opportunity guidelines (as in force at the time of application). The Grantee must notify the Commonwealth about events relating to the project and provide an opportunity for the Minister or their representative to attend. The Grantee must ensure that the grant from the MRFF is appropriately badged and acknowledged in any correspondence, public announcement and publicly available materials including: reporting of key findings; presentations; and publications relating to this activity. Project title <project title> Project scope and description <detailed project description> Project outcomes <project outcomes> Dissemination of Research Findings The Grantee will ensure that appropriate safeguards are in place to protect patient privacy, Intellectual property and commercially confidential information for all Activities funded under this Project. The Grantee is encouraged to ensure that research activities are published and translated into clinical practice. Types of research dissemination may include, making lay summaries available for research participants, and presenting at specific forums. The Grantee is also encouraged to publish de-identified research data in an open access repository and in accordance with best practice. Duration of the Grant The Activity starts on <project start date> and ends on <project end date>, which is the Activity Completion Date. The Agreement ends on <agreement end date> which is the Agreement End Date. Activity Schedule In undertaking the Activity, the Grantee will meet the following milestones by the due dates. Milestone number Milestone name and description Due date <No> <milestone name> <milestone description> <dd/mm/yyyy> Payment of the Grant The total amount of the Grant is <grant amount> (plus GST if applicable). The Grant will be provided at up to <grant percentage> per cent of eligible expenditure as defined in the grant opportunity guidelines subject to availability of Program funds. The Grant will be paid in accordance with clause ST2.. . The Grant will be paid according to the following schedule. Payments are subject to satisfactory progress on the project and compliance by the Grantee with its obligations under this Agreement. Payment event Payment amount (GST excl) Anticipated payment date <Payment trigger> <insert amount> <insert date> <Payment trigger> <insert amount> <insert date> Total <total grant amount> Invoicing The Grantee agrees to allow the Commonwealth to issue it with a Recipient Created Tax Invoice (RCTI) for any taxable supplies it makes in relation to the Activity.

Activity. The Activity is made up of the Grantee’s project and all eligible project activities as specified in these Grant Details. In undertaking the Activity, the Grantee must comply with the requirements of the grant opportunity guidelines (as in force at the time of application). The Grantee must notify the Commonwealth about events relating to the project and provide an opportunity for the Minister or their representative to attend. The Grantee must ensure that the grant from the MRFF is appropriately badged and acknowledged in any correspondence, public announcement and publicly available materials including: reporting of key findings; presentations; and publications relating to this activity. Project title <project title> Project scope and description <detailed project description> Project outcomes <project outcomes> Dissemination of Research Findings The Grantee will ensure that appropriate safeguards are in place to protect patient privacy, Intellectual property and commercially confidential information for all Activities funded under this Project. The Grantee is encouraged to ensure that research activities are published and translated into clinical practice. Types of research dissemination may include, making lay summaries available for research participants, and presenting at specific forums. The Grantee is also encouraged to publish de-identified research data in an open access repository and in accordance with best practice. Duration of the Grant The Activity starts on <project start date> and ends on <project end date>, which is the Activity Completion Date. The Agreement ends on <agreement end date> which is the Agreement End Date. Activity Schedule In undertaking the Activity, the Grantee will meet the following milestones by the due dates. Milestone number Milestone name and description Due date <No> <milestone name> <milestone description> <dd/mm/yyyy> Payment of the Grant The total amount of the Grant is <grant amount> (plus GST if applicable). The Grant will be provided at up to <grant percentage> per cent of eligible expenditure as defined in the grant opportunity guidelines subject to availability of Program funds. The Grant will be paid in accordance with clause ST2.. . The Grant will be paid according to the following schedule. Payments are subject to satisfactory progress on the project and compliance by the Grantee with its obligations under this Agreement. Payment event Payment amount (GST excl) Anticipated payment date <Payment trigger> <insert amount> <insert date> <Payment trigger> <insert amount> <insert date> Total <total grant amount> Invoicing The Grantee agrees to allow the Commonwealth to issue it with a Recipient Created Tax Invoice (RCTI) for any taxable supplies it makes in relation to the Activity.

Activity. The Activity is made up of the Grantee’s project your Project and all eligible project activities as specified in these Grant Details. [Describe the Project, i.e. what the grantee will spend the grant funds doing. It is important to include enough detail to allow the Commonwealth to judge whether what the grantee is doing/spending the grant funds on falls within the approved scope. Use the following headings] Project title Project scope and description Project Outcomes Key eligible activities The Project will involve research in a priority area specified by the department for the funding round. In undertaking the Activity, the Grantee must comply with the requirements of the grant opportunity guidelines Program Guidelines (as in force at the time of applicationfrom time-to-time). The Grantee You must notify the Commonwealth us about events relating to the project Project and provide an opportunity for the Minister or their representative to attend. The Grantee must ensure that the grant from the MRFF is appropriately badged and acknowledged in any correspondence, public announcement and publicly available materials including: reporting of key findings; presentations; and publications relating to this activity. Project title <project title> Project scope and description <detailed project description> Project outcomes <project outcomes> Dissemination of Research Findings The Grantee will ensure that appropriate safeguards are in place to protect patient privacy, Intellectual property and commercially confidential information for all Activities funded under this Project. The Grantee is encouraged to ensure that research activities are published and translated into clinical practice. Types of research dissemination may include, making lay summaries available for research participants, and presenting at specific forums. The Grantee is also encouraged to publish de-identified research data in an open access repository and in accordance with best practice. Duration of the Grant The Activity starts on <project start date> the date of execution and ends on <project end date>, which is the Activity Completion Date. The Agreement ends on <agreement end date> which is the Agreement End Date. Activity Schedule In undertaking the Activity, the Grantee will meet the following milestones by the due dates. Milestone number Milestone name and description Due 1 Project start date <No> <milestone name> <milestone description> <[dd/mm/yyyy> ] 2 [title and description of milestone, include key activities] [dd/mm/yyyy] 3 [title and description of milestone, include key activities] [dd/mm/yyyy] 4 Project end date [dd/mm/yyyy] 5 End of project report / Project evaluation [dd/mm/yyyy] Payment of the Grant The total amount of the Grant is <[grant amount> ] (plus GST if applicable). The Grant will be provided at up to <[grant percentage> ] per cent of eligible expenditure as defined in Eligible Expenditure Guide at Appendix B of the grant opportunity guidelines Program Guidelines subject to satisfactory progress towards milestones and availability of Program funds. The Grant will be paid in accordance with clause ST2.. The . An initial payment will be made on execution of the Grant Agreement based on forecast eligible expenditure for the first milestone. Subsequent payments will be paid according to the following schedulein advance as agreed milestones are achieved, based on forecast eligible expenditure and may be adjusted for unspent amounts from previous payments. Payments are subject to satisfactory progress on the project Project and compliance by the Grantee with its obligations under this Agreement. Payment event Payment amount (GST excl) Anticipated A final payment date <Payment trigger> <insert amount> <insert date> <Payment trigger> <insert amount> <insert date> Total <total grant amount> of 10 per cent of the Grant will be withheld until the Grantee submits a satisfactory end of project report demonstrating end of Project reporting obligations have been met. Invoicing The Grantee agrees to allow the Commonwealth to issue it with a Recipient Created Tax Invoice (RCTI) for any taxable supplies it makes in it relation to the Activity.

Activity. The Activity is made up of the Grantee’s project and all eligible project activities as specified in these Grant Details. In undertaking the Activity, the Grantee must comply with the requirements of the grant opportunity guidelines (as in force at the time of application). The Grantee must notify the Commonwealth about events relating to the project and provide an opportunity for the Minister or their representative to attend. The Grantee must ensure that the grant from the MRFF is appropriately badged and acknowledged in any correspondence, public announcement and publicly available materials including: reporting of key findings; presentations; and publications relating to this activity. Project title <project title> Project scope and description <detailed project description> Project outcomes <project outcomes> Dissemination of Research Findings The Grantee will ensure that appropriate safeguards are in place to protect patient privacy, Intellectual property and commercially confidential information for all Activities funded under this Project. The Grantee is encouraged to ensure that research activities are published and translated into clinical practice. Types of research dissemination may include, making lay summaries available for research participants, and presenting at specific forums. The Grantee is also encouraged to publish de-identified research data in an open access repository and in accordance with best practice. .] Duration of the Grant The Activity starts on <project start date> and ends on <project end date>, which is the Activity Completion Date. The Agreement ends on <agreement end date> which is the Agreement End Date. Activity Schedule In undertaking the Activity, the Grantee will meet the following milestones by the due dates. Milestone number Milestone name and description Due date <No> <milestone name> <milestone description> <dd/mm/yyyy> Payment of the Grant The total amount of the Grant is <grant amount> (plus GST if applicable). The Grant will be provided at up to <grant percentage> per cent of eligible expenditure as defined in the grant opportunity guidelines subject to availability of Program funds. The Grant will be paid in accordance with clause ST2.. . The Grant will be paid according to the following schedule. Payments are subject to satisfactory progress on the project and compliance by the Grantee with its obligations under this Agreement. Payment event Payment amount (GST excl) Anticipated payment date <Payment trigger> <insert amount> <insert date> <Payment trigger> <insert amount> <insert date> Total <total grant amount> Invoicing The Grantee agrees to allow the Commonwealth to issue it with a Recipient Created Tax Invoice (RCTI) for any taxable supplies it makes in relation to the Activity.